Janney Montgomery Scott LLC Novavax Inc Transaction History

Janney Montgomery Scott LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$69.73 - $142.9 $516,978 - $1.06 Million	-7,414 Closed	0 $0
Q4 2021 Jan 27, 2022	BUY	$134.56 - $217.97 $27,719 - $44,901	206 Added 2.86%	7,414 $1.06 Million
Q3 2021 Oct 29, 2021	BUY	$177.8 - $270.58 $563,270 - $857,197	3,168 Added 78.42%	7,208 $1.49 Million
Q2 2021 Jul 26, 2021	BUY	$121.0 - $257.67 $45,859 - $97,656	379 Added 10.35%	4,040 $858,000
Q1 2021 Apr 27, 2021	BUY	$112.98 - $319.93 $194,890 - $551,879	1,725 Added 89.1%	3,661 $664,000
Q4 2020 Jan 25, 2021	BUY	$78.74 - $139.5 $152,440 - $270,072	1,936 New	1,936 $216,000

286

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $713M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.